Logo

American Heart Association

  82
  0


Final ID: 4360886

Update to Non-invasive, Automated Approach to Estimate Septal Curvature as a Surrogate of Mean Pulmonary Arterial Pressure for Pediatric Pulmonary Hypertension Patients

Abstract Body (Do not enter title and authors here):
Background:
Pediatric pulmonary hypertension can be diagnosed by echocardiography and right heart catheterization, but cardiac MRI-based septal curvature (SC) measurement can also be used as a surrogate of mean pulmonary arterial pressure (mPAP), which is an invasive measurement to follow-up patients. We developed an automated approach to measure SC, demonstrating its superiority over a manual measurement. However, its performance relative to other septal wall measurements and clinical markers are unclear.

Hypothesis:
Automated SC is better correlated with mPAP, less observer dependent, and better associated with adverse outcomes than interventricular septal angle (IVS) and right ventricular ejection fraction (RVEF).

Aims:
To compare the automated SC, IVS, and RVEF in terms of observer variability, correlation to mPAP, and correlation with adverse outcomes.

Methods:
Patients with pulmonary hypertension who had both catheterization and cardiac MRI were retrospectively included. Automated SC and IVS were measured using a mid-slice of short-axis stack imaging for both ventricles using cvi42, a custom MATLAB tool and Fuji PACs (Fig.1). RVEF was collected from the MRI scan report. Adverse outcomes were death, transplant, and/or indication for transplant of heart and/or lung and were collected from electronic health record. Pearson correlation was used for correlation between the metrics and mPAP. A receiver-operating characteristic (ROC) curve was used to investigate the association between the metrics and outcomes. Intraclass correlation coefficient (ICC) was used for interobserver variability analysis. P<0.05 was considered statistically significant.

Results:
25 patients (17.0 [12.0 – 18.0] years; 13 with adverse outcomes) were included. Automated SC had a better correlation with mPAP (R=-0.82, p<0.001) than IVS (R=0.66, p<0.001) and RVEF (R=-0.49, p=0.01) (Fig.2). The capability to differentiate adverse outcomes was significant and better for RVEF (area under the curve of 0.82, p=0.007) while it was not significant for automated SC (0.72, p=0.06) and IVS (0.63, p=0.28) (Fig.3). Interobserver analysis found comparable ICCs (0.98, 95%CI, 0.97 – 0.99 for automated SC; 0.97, 95%CI 0.94 – 0.98 for IVS). ICC was not estimated for RVEF due to retrospective nature of the data collection.

Conclusion:
The automated SC better correlated with mPAP, with comparable observer dependency to IVS but was not able to better differentiate adverse outcomes than RVEF.
  • Fujiwara, Takashi  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Lu, Vivian  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Frank, Benjamin  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Ivy, Dunbar  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Fonseca, Brian  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Neves Da Silva, Helio  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Sassoon, Daniel  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Gerstner Saucedo, Jochen  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Burkett, Dale  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Browne, Lorna  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Barker, Alex  ( Children's Hospital Colorado, University of Colorado Anschutz Medical Campus , Aurora , Colorado , United States )
  • Author Disclosures:
    Takashi Fujiwara: DO NOT have relevant financial relationships | Lorna Browne: No Answer | Alex Barker: No Answer | Vivian Lu: No Answer | Benjamin Frank: No Answer | Dunbar Ivy: DO have relevant financial relationships ; Consultant:Merck:Active (exists now) ; Research Funding (PI or named investigator):Actelion:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Consultant:Actelion:Active (exists now) | Brian Fonseca: No Answer | Helio Neves da Silva: No Answer | Daniel Sassoon: No Answer | Jochen Gerstner Saucedo: DO NOT have relevant financial relationships | Dale Burkett: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Melvin Judkins Early Career Clinical Investigator Award Competition

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Abstract Oral Session

You have to be authorized to contact abstract author. Please, Login
Not Available